Gemini Space Station (GEMI) priced its IPO at $28/share. If opening trades push it far above the IPO level, the setup resembles Firefly Aerospace (FLY). Recall: FLY priced at $45, opened near $70 (+55%), then retraced as institutions took profits and retail demand cooled.
The mechanics are similar: IPO allocations often exit after early gains, while retail hype fuels stretched opens. Space IPOs in 2025 have shown this volatility. If GEMI opens 2× its IPO price, a pullback is statistically likely.
Takeaway: Monitor the opening print vs IPO price. A gap too far may offer short-term fade opportunities, just as FLY demonstrated.
The mechanics are similar: IPO allocations often exit after early gains, while retail hype fuels stretched opens. Space IPOs in 2025 have shown this volatility. If GEMI opens 2× its IPO price, a pullback is statistically likely.
Takeaway: Monitor the opening print vs IPO price. A gap too far may offer short-term fade opportunities, just as FLY demonstrated.
Note
I was comparing IPO hype, but I wrongly described GEMI as a space play—unlike Firefly (FLY), GEMI’s business is in crypto, not aerospace.Note
GEMI’s IPO was oversubscribed ~20×, compared to Bullish’s 12–15× that peaked around 3× IPO, which suggests demand could drive GEMI toward a 4× multiple (~$112) in the first session. The Winklevoss name adds extra retail hype, increasing odds of a short-term spike. If that happens, short-dated puts (10–14 days) would likely price at roughly 10% of the stock value, meaning about $10–12 per share at those levels, reflecting high implied volatility in debut IPO options.Note
Plan: buy puts if GEMI spikes to $110–115, then sell into the fade.Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.